Plasma Soluble Dipeptidyl Peptidase-4 and Risk of Major Cardiovascular Events After Ischemic Stroke: Secondary Analysis of China Antihypertensive Trial in Acute Ischemic Stroke (CATIS)

Recent studies have suggested that plasma soluble dipeptidyl peptidase-4 (sDPP4) have important physiological effects, which may influence the prognosis of ischemic stroke. Our study aimed to examine the relationship between plasma sDDP4 levels and long-term clinical outcomes among acute ischemic st...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Neurology 2022-08, Vol.99 (9), p.e925-e934
Hauptverfasser:	You, Shoujiang, Miao, Mengyuan, Lu, Zian, Bao, Anran, Du, Jigang, Che, Bizhong, Xu, Tan, Zhong, Chongke, Cao, Yongjun, Liu, Chun-Feng, Zhang, Yonghong, He, Jiang
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!